Photo

613-567-0762

...

Ottawa

English

Tanya Weston

Associate

Tanya Weston’s practice focuses mainly on patent and regulatory matters related to pharmaceutical, biotechnology and medical device patents and applications. Tanya is a co-founding member of the firm’s Regulatory Working Group and regularly advises clients on issues relating to regulatory approval, market exclusivity and the pricing and reimbursement of pharmaceuticals and biologics.

Tanya is a regular guest lecturer at the University of Ottawa, Faculty of Common Law, on issues related to the Patented Medicine Prices Review Board, Canada’s Access to Medicines Regime and the listing and interchangeability of drug products at the provincial and territorial level as part of a larger course on intellectual property law as it relates to biotechnology and pharmaceuticals.

Prior to joining MBM, Tanya worked at Health Canada in various regulatory roles related to the application, enforcement and amendment of the Food & Drug Regulations. Tanya also worked at a pharmaceutical research unit in the United Kingdom, where she conducted drug safety and efficacy studies.

Tanya is a Registered Canadian Trade-mark Agent.

Education

  • B.Sc., Nutritional Sciences, Mount Saint Vincent
  • M.Sc., Community Health and Epidemiology, Queen’s University
  • LL.B., University of Ottawa

Professional Involvement

 Law Society of Upper Canada (Ontario) 

Technology Area

cb photo_89_4ee644abb983d

HEATHER GALLANT

Associate


Heather negotiates and drafts agreements related to intellectual property.
MBM read_more_btn

MBM logo

About MBM

The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More